About Caring4Diabetes

 
Caring4Diabetes's mission is to provide a complete source of knowledge and support for people with arthritis, empowering them with the expertise, strength and hope they need to live their lives to the fullest. Caring4Diabetes combines a virtual encyclopedia of cancer information with a collection of powerful tools that help patients take an active role in managing their disease. Our rheumatologists and orthopaedists review our content for accuracy and timeliness.

At Caring4Diabetes, you can:

  • Shape the content to match your specific arthritis type, diagnosis, and phase of treatment or recovery
  • Interact with other patients and experts through our message boards
  • Keep track of your symptoms, treatments, and appointments with a secure Patient Health Record and Symptom Tracker
  • Sign up for e-newsletters tailored to your interests and needs.
  • Create your own personal web page where you can keep a personal journal, exchange messages of encouragement, share pictures, and more.

Hundreds of arthritis practices are now prescribing Caring4Diabetes’s educational and interactive tools to their patients, just as they prescribe medication or therapy.However, the content at Caring4Diabetes is not intended to be a substitute for professional medical advice, diagnosis, or treatment. For information on how to contact us, please click here.

Latest Diabetes Topics News
In tough economic times, NIH head looks to clinic

January 25, 2010 — WASHINGTON (Reuters) - As he puts together his budget proposal for the coming year, National Institutes of Health director Dr. Francis Collins plans to do something a little different - emphasizing the "health" in the name of his U.S. agency.

Mother jailed for "sickest boy in Britain" fantasy

January 22, 2010 — LONDON (Reuters Life!) - A mother was jailed on Friday for pretending that her healthy son was "the sickest boy in Britain" and needed to be fed through a tube and be taken to school in a wheelchair.

EU agency urges ban on diet drug

January 21, 2010 — WASHINGTON (Reuters) - European authorities urged a halt to sales of an Abbott Laboratories Inc diet pill on Thursday after concluding risks were too high, while U.S. regulators said they had asked for a stronger warning.

Select news items provided by Reuters Health